Arcadia Biosciences (NASDAQ:RKDA) is up 8% premarket on light volume on the heels of its announcement that it plans to add its new reduced gluten wheat lines to its GoodWheat portfolio of branded ingredients. The first bread flour should be available for commercial testing by year-end.



READ SOURCE

MUST READ  USD/CAD Eyes November-Low (1.2666) Ahead of BoC Rate Decision
SHARE

LEAVE A REPLY

Please enter your comment!
Please enter your name here